Percheron Therapeutics Ltd (PER) — Cash Flow Reinvestment Rate

Latest as of September 2015: 0.01x

Percheron Therapeutics Ltd (PER) has a Cash Flow Reinvestment Rate of 0.01x as of September 2015, reinvesting AU$1.90K (capex AU$1.90K ) from operating cash flow of AU$317.22K. See PER free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.01x

(Capex + Investments) / Operating CF

Total Reinvested

AU$1.90K

Capex + Investments

Operating Cash Flow

AU$317.22K

AUD

Capital Expenditures

AU$1.90K

AUD

Percheron Therapeutics Ltd Cash Flow Reinvestment Rate (2015–2015)

Historical reinvestment intensity for Percheron Therapeutics Ltd across 1 annual periods. For the full cash flow conversion analysis, see Percheron Therapeutics Ltd operating cash flow efficiency.

Annual Cash Flow Reinvestment Rate for Percheron Therapeutics Ltd (2015–2015)

Year-by-year capital reinvestment analysis for Percheron Therapeutics Ltd. See Percheron Therapeutics Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (AUD)	Operating CF	Capex	YoY Change
2015	1.89x	AU$2.40 Million	AU$1.27 Million	AU$3.86K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow